Professor of Medicine and Pharmacy Univ of Pittsburgh; Senior Medical Director, Center for Value Based Pharmacy Initiatives, UPMC Health Plan. Opinions mine

Pittsburgh, PA
Joined July 2009
💊 A new study by @CBGood23 & colleagues sheds light on demographic & clinical profiles of very high-cost #pharmaceutical users, revealing key 💵 drivers like HIV, cancer, & inflammatory conditions. Learn more about rising drug costs & policy solutions: journals.lww.com/lww-medical…
1
5
253
A retrospective cross-sectional multi-year study by Samuel Peasah, @CBGood23, & colleagues found csDMARDs were highly used consistently in patients with #RheumatoidArthritis. Read more about their results in @DrugsRWOutcomes: link.springer.com/article/10…
2
3
344
Samuel Peasah, @CBGood23, & more found a financial incentive & refill reminder program was associated with improved adherence to antithrombotic meds, reduced ED use, & increased RX costs, but not in total pharmacy, medical, or total cost of care. 🗞️ jmcp.org/doi/10.18553/jmcp.2…
1
2
233
Come and learn how @icer_review, @Highmark_BCBS, @MassHealth, and Canada are assessing prescription digital therapeutics on Friday, Oct 13. Moderated by @CBGood23 and @SuzanneMcgurn. Brought to you by the ISPOR #HTA Roundtable - North America.
Are you interested in the payer perspective of prescription digital therapeutics? Join us to learn how payers and #HTA bodies from North America assess #digitaltherapies for safety, effectiveness, and value at a webinar on October 13. ow.ly/SL4t50PS8wt
2
3
509
Findings suggest PPPM total cost of care of patients receiving empagliflozin was similar to PPPM total cost of care of patients receiving nonempagliflozin antidiabetic medications. Read more from @CBGood23 & colleagues: ow.ly/bBKt50ML9W5
1
2
317
An #invitedcommentary by @CBGood23 & @ihdezdelso in @JAMAHealthForum gives insight to possible reasons for rising #drugcosts 📈 Read it here: ow.ly/PKYq50LepqO
2
2
Bernie Good retweeted
Tune in to our interview with Dr Chester "Bernie" Good (@CBGood23), senior medical director of the Center for Value Based Pharmacy Initiatives at @UPMCHealthPlan, as he talks about the evolution of value-based contracts. ow.ly/l5oA50LaWAC
‼️ New Paper ‼️ Our team has spent the last 3 years trying to answer the question: does where you live impact if you receive blood thinners for #AFib. Short answer: YES! A journey to what we found, what it means, and what we can do about it. rdcu.be/cWdBf 1/ 🧵
4
57
6
185
We were asked to write about balance of harms and benefits of antidepressants based on current knowledge for @DTB_BMJ, a BMJ journal that is famously independent and does not take pharma sponsorship/advertising bit.ly/3mnJXNn 1/n
8
113
33
222
In this study by @CBGood23 & colleagues from the UPMC Center for High-Value Health Care and @Evernorth, the ticagrelor cohort had the highest medication adherence & the clopidogrel cohort had the highest readmission rate. Full test available 👉 ow.ly/Lykw50GTxfQ
2
3
Switching from dipeptidyl peptidase-4 inhibitors to glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter 2 inhibitors was associated with fewer hospitalizations; however, higher #pharmacy costs. @amcporg study with PittGIM's @CBGood23: jmcp.org/doi/pdf/10.18553/jm…
3
5
Analysis in @JournalGIM does not support the supposition that access to #marijuana lowers use of chronic #opioids for pain. Study including PittGIM's @CBGood23. @ParekhNatasha @UPMCHealthPlan link.springer.com/article/10…
New year, new publication! CP3's @asjrodriguez, @CBGood23, @walidgellad, @ihdezdelso with @pittpharmacy's Vincent Piro examined price trends of injectable TNF factors and found net prices of adalimumab tripled. pubmed.ncbi.nlm.nih.gov/3337… @PittGIM @vaequity @PittHealthSci
3
4
As employers attempt to understand the value of carving in versus carving out pharmacy benefits to health plans, @amcporg study with PittGIM's @CBGood23 suggests that carving in pharmacy benefits is associated with reduced medical costs & hospitalizations. jmcp.org/doi/10.18553/jmcp.2…
Seems like two cases of transverse myelitis in one of the major vaccine trials. Terrible news, a reminder that research participants take on risk for all of us. Also a reminder that we should invest in public health even while we wait for a vaccine. nytimes.com/2020/09/19/healt…
5
28
6
101
Addressing the challenges of deprescribing creates an important opportunity to lower prescription drug burden and resultant harms among older, fragile, and complex adults. In @JournalGIM by @ParekhNatasha, PittGIM's @SchenkerYael & @CBGood23, @willshrank. link.springer.com/article/10…
3
2
New study in @JournalGIM by @ihdezdelso, @asjrodriguez, & PittGIM's @CBGood23 & @walidgellad demonstrates that the majority of Medicare Part D discounts originate from 6 therapeutic classes, w/ 10 drugs accounting for ~1/2 of all Medicare Part D discounts. link.springer.com/article/10…
1
2
New paper in @JournalGIM from our top drug price research team of @ihdezdelso, @asjrodriguez, @CBGood23, & @walidgellad determined that most #Medicare Part D discounts originate from a few therapeutic classes of drugs. link.springer.com/article/10…
4
7
After seeing patients all day, my Dad is going to settle into his office, open up his weekly copy of @NEJM and see his son’s name in it. And that makes all of this worth it. 🙏🏾 Thanks @QuentinYoumans @DrQuinnCapers4 for the collab. #BlackMenInMedicine nejm.org/doi/full/10.1056/NE…
66
226
56
2,006
Correlation is not causation but 52% of the deceased in Italy were on either an ACE or an ARB. This is noteworthy and warrants further research. – at Needham, MA
This Post is from an account that no longer exists. Learn more
1
1